惰性淋巴瘤:解决幸存者的需要
Pasquale L Fedele1, Stephen Opat1
1School of Clinical Sciences at Monash Health, Lymphoma Research Group, Monash University, Clayton, Australia.
Leukemia & lymphoma
|January 29, 2025
概括
惰性淋巴瘤 (iNHL) 患者的寿命更长,但面临终身并发症. 未来的护理必须在初始治疗之外解决这些长期问题,以改善患者的福祉.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 公共卫生 公共卫生
背景情况:
- 在过去的二十年中,惰性淋巴瘤 (iNHL) 的结局显著改善.
- 增加的生存率导致INHL幸存者的人口不断增长.
- 目前的护理模式不足以满足INHL幸存者的终身,多方面的需求.
研究的目的:
- 突出对惰性淋巴瘤幸存者的综合护理模式的需要.
- 确定需要关注的长期患者福祉的关键领域.
- 倡导对iNHL幸存者护理采取更广泛的方法.
主要方法:
- 关于INHL结果和生存挑战的文献综述.
- 对 iNHL 目前临床护理模型的分析.
- 识别常见的长期并发症和未满足的需求.
主要成果:
- 惰性淋巴瘤幸存者经历了持续的身体,情感,心理和社会挑战.
- 关键的关注领域包括感染风险,二次恶性瘤,心血管疾病,骨健康和性健康.
- 现有的护理框架往往无法整合这些幸存者问题的管理.
结论:
- 在iNHL中提高生存率需要转向整体的,长期的生存护理.
- 初级保健医生需要指导来管理INHL幸存者的复杂需求.
- 涉及患者,护理人员和医疗保健提供者的综合护理对于优化INHL幸存者的生活质量至关重要.
相关概念视频
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Primary Lymphoid Organs
9.6K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
9.6K
Secondary Lymphoid Organs
7.2K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
7.2K
Development of the Lymphatic System
2.8K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.8K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K


